Corea L - Search Results

1

Stable angina pectoris and controlled ischemia: what causes the abnormalities in whole blood filterability?

Ciuffetti G, Mercuri M, Lombardini R, Bellomo G, Corea L, Lowe GD, Ventura A. Ciuffetti G, et al. Among authors: corea l. Am Heart J. 1990 Jan;119(1):54-8. doi: 10.1016/s0002-8703(05)80081-x. Am Heart J. 1990. PMID: 2296874

2

Low-dose dipyridamole infusion acutely increases exercise capacity in angina pectoris: a double-blind, placebo controlled crossover stress echocardiographic study.

Tommasi S, Carluccio E, Bentivoglio M, Corea L, Picano E. Tommasi S, et al. Among authors: corea l. J Am Coll Cardiol. 2000 Jan;35(1):83-8. doi: 10.1016/s0735-1097(99)00534-3. J Am Coll Cardiol. 2000. PMID: 10636264 Free article. Clinical Trial.

3

C-reactive protein as a marker for cardiac ischemic events in the year after a first, uncomplicated myocardial infarction.

Tommasi S, Carluccio E, Bentivoglio M, Buccolieri M, Mariotti M, Politano M, Corea L. Tommasi S, et al. Among authors: corea l. Am J Cardiol. 1999 Jun 15;83(12):1595-9. doi: 10.1016/s0002-9149(99)00162-9. Am J Cardiol. 1999. PMID: 10392860

4

Leucocyte rheology in controlled coronary ischaemia.

Ciuffetti G, Bellomo G, Mercuri M, Lombardini R, Savino K, Corea L. Ciuffetti G, et al. Among authors: corea l. Int J Cardiol. 1989 Nov;25(2):193-8. doi: 10.1016/0167-5273(89)90107-1. Int J Cardiol. 1989. PMID: 2807607

5

Leucocytes and free radicals in stable angina pectoris.

Ciuffetti G, Corea L, Mannarino E, Mercuri M, Lombardini R, Santambrogio L. Ciuffetti G, et al. Among authors: corea l. Jpn Heart J. 1992 Mar;33(2):145-57. doi: 10.1536/ihj.33.145. Jpn Heart J. 1992. PMID: 1317470

6

Usefulness of the severity and extent of wall motion abnormalities as prognostic markers of an adverse outcome after a first myocardial infarction treated with thrombolytic therapy.

Carluccio E, Tommasi S, Bentivoglio M, Buccolieri M, Prosciutti L, Corea L. Carluccio E, et al. Among authors: corea l. Am J Cardiol. 2000 Feb 15;85(4):411-5. doi: 10.1016/s0002-9149(99)00764-x. Am J Cardiol. 2000. PMID: 10728942

7

Verapamil 240 SR versus verapamil 120 SR in arterial hypertension. A randomized double-blind, placebo-controlled study with 24-hour ambulatory blood pressure monitoring.

Corea L, Bentivoglio M, Berioli S, Bianchini C, Savino K, Sardina M. Corea L, et al. Cardiovasc Drugs Ther. 1990 Dec;4(6):1501-7. doi: 10.1007/BF02026498. Cardiovasc Drugs Ther. 1990. PMID: 2081142 Clinical Trial.

8

Similarities and differences in the antihypertensive effect of two calcium antagonist drugs, verapamil and nifedipine.

Agabiti-Rosei E, Muiesan ML, Romanelli G, Castellano M, Beschi M, Corea L, Muiesan G. Agabiti-Rosei E, et al. Among authors: corea l. J Am Coll Cardiol. 1986 Apr;7(4):916-24. doi: 10.1016/s0735-1097(86)80357-6. J Am Coll Cardiol. 1986. PMID: 3514729 Free article.

9

Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: a comparative study of the efficacy and safety against amlodipine.

Corea L, Cardoni O, Fogari R, Innocenti P, Porcellati C, Provvidenza M, Meilenbrock S, Sullivan J, Bodin F. Corea L, et al. Clin Pharmacol Ther. 1996 Sep;60(3):341-6. doi: 10.1016/S0009-9236(96)90061-2. Clin Pharmacol Ther. 1996. PMID: 8841157 Clinical Trial.

10

[Septal hypertrophy in the hypertensive patient: clinical reality or curiosity].

Corea L, Bentivoglio M. Corea L, et al. Cardiologia. 1996 Oct;41(10):937-44. Cardiologia. 1996. PMID: 8983823 Review. Italian. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results